Pharmaniaga Berhad (Pharmaniaga) is a

Malaysia Malaysia is a country in Southeast Asia. Featuring the Tanjung Piai, southernmost point of continental Eurasia, it is a federation, federal constitutional monarchy consisting of States and federal territories of Malaysia, 13 states and thre ...

pharmaceutical Medication (also called medicament, medicine, pharmaceutical drug, medicinal product, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy ( pharmacotherapy) is an important part of the ...

company. It is a subsidiary of

Boustead Holdings Boustead Holdings Berhad (BHB) () is a Malaysian corporation with over 16,000 employees across more than 90 listed and non-listed companies in Malaysia, Indonesia and the United Kingdom. It is an affiliate of the Malaysian Armed Forces, Malaysian ...

, an affiliate of the Malaysian military.

History

Pharmaniaga was established in 1994 as ''Remedi Pharmaceuticals''. The company was renamed as ''Pharmaniaga'' in August 1998 and is the first healthcare company in Malaysia to be listed in the Main Market of Kuala Lumpur Stock Exchange (now

Bursa Malaysia Bursa Malaysia (English: Malaysian Bourses or Malaysia Exchange) is the stock exchange in Malaysia. It is one of the largest bourses in ASEAN. It is based in Kuala Lumpur and was previously known as the Kuala Lumpur Stock Exchange (KLSE). It p ...

).Pharmaniaga Berhad: An analysis
UK Essay (April 5, 2017). Retrieved on April 5, 2017.

Ownership

Pharmaniaga is a public limited company. Its two major shareholders are

and

Lembaga Tabung Angkatan Tentera The Armed Forces Fund Board (also commonly known by its Malay language, Malay name Lembaga Tabung Angkatan Tentera and LTAT in short) is a statutory authority, statutory body which manages the pension, pension fund for certain members of the Malay ...

(LTAT). The major owner of Boustead Holdings is itself LTAT. The Company's Board Members comprise Dato’ Seri Abdul Razak Jaafar, Independent Non-Executive Chairman; Zulkifli Jafar, Managing Director; Dr Abdul Razak Ahmad, Senior Independent Non-Executive Director; Izaddeen Daud, Non-Independent Non-Executive Director; Sarah Azreen Abdul Samat, Independent Non-Executive Director; Mohammad Ashraf Md. Radzi, Non-Independent Non-Executive Director; Dato’ Mohd Zahir Zahur Hussain, Independent Non-Executive Director; Dato’ Dr Faridah Aryani Md Yusof, Independent Non-Executive Director; Drs Imam Fathorrahman, Independent Non-Executive Director; Dr Mary Jane Cardosa, Independent Non-Executive Director; Dato’ Seri Dr Awaludin Said, Independent Non-Executive Director and Mohd Firdaus Zulkifli, Non-Independent Non-Executive Director (Alternate Director to Mohammad Ashraf Md. Radzi).

Business Overview

Pharmaniaga's expertise extends beyond manufacturing, encompassing logistics and distribution, as well as dynamic sales and marketing strategies that ensure their products reach those in need nationwide. Pharmaniaga has over 3,400 employees, and more than 200 scientific and technical experts across various disciplines. With five manufacturing plants, including Indonesia plant, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, diabetes, anti-infectives, pain management, and respiratory, amongst others. Its Indonesia operations comprise PT Errita Pharma (Errita) and PT Millennium Pharmacon International Tbk (MPI). MPI is a public listed company on the Indonesia Stock Exchange with 35 branches nationwide. Meanwhile, Errita produces over 60 generic pharmaceuticals as well as over-the-counter products.

References

{{authority control Government-owned companies of Malaysia Companies listed on Bursa Malaysia Pharmaceutical companies of Malaysia Pharmaceutical companies established in 1994 Companies based in Shah Alam 1994 establishments in Malaysia Malaysian brands